Faculty Publications

As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.

Total number of publications: 7,082

Enter a faculty name:

Administrative Offices

Graduate Schools

Health Sciences

Lander Colleges

Law Center

New York School of Career and Applied Studies (NYSCAS)

Touro University System

First Prev 1 2 3 4 5 6 7 8 9 Next Last
  • Citrome, L. (2015). My two favourite professional social networking sites: LinkedIn and ResearchGate - how they can help you, or hurt you. International Journal of Clinical Practice, 69(6), 623-624. doi:10.1111/ijcp.12681

  • Citrome, L. (2015). Partial and non-adherence: We need all the help we can get. International Journal of Clinical Practice, 69(1), 1-2. doi:10.1111/ijcp.12610

  • Citrome, L. (2015). The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: The 15-min challenge to sort these agents out. International Journal of Clinical Practice, 69(11), 1211-1220. doi:10.1111/ijcp.12752

  • Citrome, L. (2015). Transdermal patches: How common are application site reactions and how severe are they? International Journal of Clinical Practice, 69(5), 509-510. doi:10.1111/ijcp.12668

  • Citrome, L. (2015). Vilazodone, levomilnacipran and vortioxetine for major depressive disorder: The 15-min challenge to sort these agents out. International Journal of Clinical Practice, 69(2), 151-155. doi:10.1111/ijcp.12620

  • Citrome, L. (2015). What is good publication practice, what is ISMPP, and why you should care. International Journal of Clinical Practice, 69(9), 913-914. doi:10.1111/ijcp.12725

  • Citrome, L. (2016). Aripiprazole long-acting injectable formulations for schizophrenia: Aripiprazole monohydrate and aripiprazole lauroxil. Expert Review of Clinical Pharmacology, 9(2), 169-186. doi:10.1586/17512433.2016.1121809

  • Citrome, L. (2016). Breakthrough drugs for the interface between psychiatry and neurology. International Journal of Clinical Practice, 70(4), 298-299. doi:10.1111/ijcp.12805

  • Citrome, L. (2016). Cariprazine for the treatment of schizophrenia: A review of this dopamine D3-preferring D3/D2 receptor partial agonist. Clinical Schizophrenia & Related Psychoses, 10(2), 109-119. doi:10.3371/1935-1232-10.2.109

  • Citrome, L. (2016). Emerging pharmacological therapies in schizophrenia: What's new, what's different, what's next? CNS Spectrums, 21(S1), 1-12. doi:10.1017/S1092852916000729

  • Citrome, L. (2016). Food for thought: Do you ask about eating? International Journal of Clinical Practice, 70(7), 516-517. doi:10.1111/ijcp.12845

  • Citrome, L. (2016). From banknotes to people: One million is impressive. International Journal of Clinical Practice, 70(9), 702-703. doi:10.1111/ijcp.12875

  • Citrome, L. (2016). How do I get my manuscript accepted? Steps and missteps. International Journal of Clinical Practice, 70(2), 97-98. doi:10.1111/ijcp.12782

  • Citrome, L. (2016). More food for thought: Preferred words. International Journal of Clinical Practice, 70(8), 640. doi:10.1111/ijcp.12865

  • Citrome, L. (2016). Open researcher and contributor ID: ORCID now mandatory for Wiley journals. International Journal of Clinical Practice, 70(11), 884-885. doi:10.1111/ijcp.12912

  • Citrome, L. (2016). Peer review and Publons - enhancements for the reviewer. International Journal of Clinical Practice, 70(5), 364. doi:10.1111/ijcp.12827

  • Citrome, L. (2016). Perceptions matter: Attitudes and health outcomes. International Journal of Clinical Practice, 70(12), 966. doi:10.1111/ijcp.12923

  • Citrome, L. (2016). Rosacea and dementia: Relative vs. absolute effect sizes. International Journal of Clinical Practice, 70(6), 428-429. doi:10.1111/ijcp.12834

  • Citrome, L. (2016). Schizophrenia relapse, patient considerations, and potential role of lurasidone. Patient Preference and Adherence, 10, 1529-1537. doi:10.2147/PPA.S45401

  • Citrome, L. (2016). The grey literature is far from drab. International Journal of Clinical Practice, 70(10), 790. doi:10.1111/ijcp.12899

  • Citrome, L. (2016). Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed. Journal of Affective Disorders, 196, 225-233. doi:10.1016/j.jad.2016.02.042

  • Citrome, L. (2016). What's in a name? Use of brand vs. generic drug names. International Journal of Clinical Practice, 70(1), 3-4. doi:10.1111/ijcp.12772

  • Citrome, L. (2016). Which role for brexpiprazole, a new dopamine D2 partial agonist, in the treatment of schizophrenia? Evidence-Based Mental Health, 19(2), e6. doi:10.1136/eb-2015-102143

  • Citrome, L. (2016). Zika and you. International Journal of Clinical Practice, 70(3), 181-182. doi:10.1111/ijcp.12793

  • Citrome, L., & Ketter, T. A. (2013). When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed. International Journal of Clinical Practice, 67(5), 407-411. doi:10.1111/ijcp.12142

First Prev 1 2 3 4 5 6 7 8 9 Next Last